Pier Capital LLC Acquires Shares of 67,061 Addus HomeCare Co. (NASDAQ:ADUS)

Pier Capital LLC bought a new position in Addus HomeCare Co. (NASDAQ:ADUS) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 67,061 shares of the company’s stock, valued at approximately $8,406,000. Pier Capital LLC owned about 0.37% of Addus HomeCare at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ADUS. Wasatch Advisors LP lifted its stake in Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares during the last quarter. State Street Corp raised its holdings in shares of Addus HomeCare by 4.4% in the third quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after buying an additional 27,990 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Addus HomeCare by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock valued at $56,406,000 after acquiring an additional 28,284 shares during the period. Finally, TimesSquare Capital Management LLC grew its position in Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after acquiring an additional 78,835 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Addus HomeCare Trading Up 1.3 %

Shares of NASDAQ:ADUS opened at $90.98 on Tuesday. The company has a market capitalization of $1.65 billion, a PE ratio of 20.82, a P/E/G ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72. The business’s fifty day simple moving average is $111.13 and its 200-day simple moving average is $121.48.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Research analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ADUS. Macquarie reissued an “outperform” rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Stephens reaffirmed an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Oppenheimer raised their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.